Information Provided By: 
Fly News Breaks for May 23, 2019
TTOO
May 23, 2019 | 12:39 EDT
JonesTrading analyst Soumit Roy views the selloff in shares of T2 Biosystems as a buying opportunity. A recently published clinical study report in a peer reviewed journal concluded that the T2bacteria panel "rapidly and accurately" diagnoses blood stream infections caused by five most common bacteria, Roy tells investors in a research note. He believes the market reaction to recent investor concerns are overblown and reiterates a Buy rating on T2 Biosystems with a $12 price target.
News For TTOO From the Last 2 Days
There are no results for your query TTOO
